These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2019417)
1. Morphological evidence for chronic mast cell activation after prolonged exposure with supernatants from chronic graft-versus-host splenocytes. Levi-Schaffer F; Segal V; Mekori YA; Claman HN; Hammel I Immunol Lett; 1991 Jan; 27(1):13-8. PubMed ID: 2019417 [TBL] [Abstract][Full Text] [Related]
2. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease. Levi-Schaffer F; Segal V; Barak V; Rubinchik E; Nagler A Exp Hematol; 1997 Mar; 25(3):238-45. PubMed ID: 9091300 [TBL] [Abstract][Full Text] [Related]
3. Histamine release from mouse and rat mast cells cultured with supernatants from chronic murine graft-vs-host splenocytes. Levi-Schaffer F; Mekori YA; Segal V; Claman HN Cell Immunol; 1990 Apr; 127(1):146-58. PubMed ID: 1690607 [TBL] [Abstract][Full Text] [Related]
4. Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease. Levi-Schaffer F; Goldenhersh MA; Segal V; Nagler A Bone Marrow Transplant; 1997 Apr; 19(8):823-8. PubMed ID: 9134176 [TBL] [Abstract][Full Text] [Related]
5. Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts. Nagler A; Segal V; Slavin S; Levi-Schaffer F Clin Exp Immunol; 1995 Jun; 100(3):529-35. PubMed ID: 7539727 [TBL] [Abstract][Full Text] [Related]
8. Mast Cell and Fibroblast Functional Activity Are Affected by Immunocompetent Cells in Chronic Grafts-vs.-Host Disease. Levi-Schaffer F; Segal V; Nagler A Int Arch Allergy Immunol; 1992; 99(2-4):238-241. PubMed ID: 34167208 [TBL] [Abstract][Full Text] [Related]
9. Suppressor function of liver mononuclear cells isolated during murine chronic graft-vs-host disease. II. Role of prostaglandins and interferon-gamma. Howell CD; Yoder TY; Vierling JM Cell Immunol; 1992 Mar; 140(1):54-66. PubMed ID: 1531454 [TBL] [Abstract][Full Text] [Related]
10. Effect of coculture of rodent mast cells with murine chronic graft-versus-host disease (cGVHD)-derived fibroblasts. Levi-Schaffer F; Segal V; Baram D; Mekori YA J Allergy Clin Immunol; 1992 Feb; 89(2):501-9. PubMed ID: 1371296 [TBL] [Abstract][Full Text] [Related]
11. Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis. Claman HN; Jaffee BD; Huff JC; Clark RA Cell Immunol; 1985 Aug; 94(1):73-84. PubMed ID: 4016962 [TBL] [Abstract][Full Text] [Related]
12. Mast cells and fibroblasts: two interacting cells. Rubinchik E; Levi-Schaffer F Int J Clin Lab Res; 1994; 24(3):139-42. PubMed ID: 7819593 [TBL] [Abstract][Full Text] [Related]
20. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect. Ilan Y; Margalit M; Ohana M; Gotsman I; Rabbani E; Engelhardt D; Nagler A Hum Immunol; 2005 Mar; 66(3):231-40. PubMed ID: 15784461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]